Topical tranexamic acid effect on blood loss in hip fractured patients undergoing cemented bipolar hemiarthroplasty : A randomized controlled trial

Phase 4

Completed

• Conditions: Blood loss; Hemi hip replacement; Tranexamic acid

• Registration Number: TCTR20201224005
• Lead Sponsor: Faculty of Medicine, Prince of Songkla University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-12-31
• Study Start: 2020-12-24
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

Patient with femoral neck fracture
Age > 60 year-old
Schedule for Bipolar hemi hip arthroplasty

Exclusion Criteria

previous hip surgery
pathological fracture
allergic to tranexamic acid
history of venous thromboembolism
history of coagulation disorder
history of hip infection.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total blood loss 24 hour calculated from reduction of Hct at 24 hour

Secondary Outcome Measures

Name	Time	Method
Complication (DVT, PE) 3 day Evaluated from clinical, ultrasonography and CT scan